Indo Global Journal of Pharmaceutical Sciences: Announcements

Prof. Gökhan Zengin is new Co-Editor-in-Chief of Indo Global Journal of Pharmaceutical Sciences

Wed, 22 Feb 2023 02:48:51 +0000

We are pleased to inform you all that Prof. Gokhan Zengin from Turkey has joined the journal as Co-Editor-in-Chief. Under his guidance, we will improve and uplift our journal's standards and make it a more suitable platform for researchers to showcase their work.

Prof. Zengin doesn't need any introduction. He is one of the most recognized researchers. According to Scopus, he has published more than 700 articles in high-repute journals. He is a kind, diligent, and very active researcher.

Regards

Dr. Rajeev K. Singla

A new malpractice being observed: Reviewers asking their own papers to cite

Tue, 13 Sep 2022 12:09:43 +0000

We strongly condemn the method adopted by the reviewers to increase the citations of their own published papers. We have observed that while reviewing, reviewers mention their own papers and ask authors to cite those papers while revising the manuscript.
Considering that adding the reviewer's papers will increase the chance of acceptance, so that author's do not argue and simply add those papers. But this is a serious offense and editors have reported such cases very often these days.
We strongly condemn and depreciate such behavior of the reviewers. We suggest all such reviewers to stop such practices, not only while reviewing the articles in Indo Global Journal of Pharmaceutical Sciences, but also for all the journals and publishers. Such practice of citations increase will not actually make your work impactful. If your work will be good, it will surely be read and cited by other authors. So, be patient and be ethical while reviewing the papers.
Regards
Dr. Rajeev K Singla
Editor-in-Chief
https://lnkd.in/dQh3py8e
#Reviewer #Citation #malpractice #pharmaceutical

100% APC waiver for Monkeypox related paper

Mon, 08 Aug 2022 09:21:26 +0000

Good News For Authors

100% APC waiver for Monkeypox related paper in Indo Global Journal of Pharmaceutical Sciences

Last Date: 20.08.2022

Https://igjps.com

100% APC Waiver for Authors from “Group A” Category Countries Indicated by Research4Life

Mon, 08 Aug 2022 09:14:24 +0000

We have observed the policies of Research4Life and would like to comply with their objectives by providing 100% APC waivers to the authors belonging to the countries from “Group A” categories. In order to be eligible, the first author and corresponding author should be from the “Group A” category countries. The purpose is to support those researchers and remove the hindrance of Article Processing Charges for them.

Group A countries are as below:

Afghanistan
Angola
Bangladesh
Belize
Benin
Bhutan
Burkina Faso
Burundi
Cambodia
Cameroon
Cabo Verde
Central African Republic
Chad
Comoros
Congo
Cook Islands
Côte d’Ivoire
Democratic People’s Republic of Korea
Democratic Republic of the Congo
Djibouti
Dominica
Equatorial Guinea
Eritrea
Eswatini
Ethiopia
Gambia
Ghana
Grenada
Guinea
Guinea-Bissau
Guyana
Haiti
Kenya
Kiribati
Kyrgyzstan
Lao People’s Democratic Republic
Lesotho
Liberia
Madagascar
Malawi
Maldives

Mali
Marshall Islands
Mauritania
Micronesia (Federated States of)
Mozambique
Myanmar
Nauru
Nepal
Nicaragua
Niger
Niue
Palau
Papua New Guinea
Republic of Moldova
Rwanda
Saint Helena
Saint Lucia
Saint Vincent and the Grenadines
Samoa
Sao Tome and Principe
Senegal
Sierra Leone
Solomon Islands
Somalia
South Sudan
Sudan
Suriname
Syrian Arab Republic
Tajikistan
Timor-Leste
Togo
Tokelau
Tonga
Tuvalu
Uganda
United Republic of Tanzania
Vanuatu
Yemen
Zambia
Zimbabwe

This policy will be effective from 13th May 2022 and will be applicable for all the publications submitted from 2022 onwards.